|
Sign In to gain access to subscriptions and/or personal tools.
|
The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits
Wojciech Wojakowski
Department of Experimental and Clinical Biochemistry Silesian Medical Academy, Katowice, Poland, wojwoj{at}mp.pl, First Clinic of Internal Medicine Silesian Medical Academy, Katowice, Poland
Jan Gminski
Department of Experimental and Clinical Biochemistry Silesian Medical Academy, Katowice, Poland, First Clinic of Internal Medicine Silesian Medical Academy, Katowice, Poland
Krzysztof Siemianowicz
Department of Experimental and Clinical Biochemistry Silesian Medical Academy, Katowice, Poland, First Clinic of Internal Medicine Silesian Medical Academy, Katowice, Poland
Malgorzata Goss
Department of Experimental and Clinical Biochemistry Silesian Medical Academy, Katowice, Poland
Marek Machalski
First Clinic of Internal Medicine Silesian Medical Academy, Katowice, Poland
Aortic elastin turnover is significantly accelerated in atherosclerosis, partly because of activation of the renin-angiotensin-aldosterone system caused by hypercholesterolaemia. We postulated that angiotensin-converting enzyme inhibitors (ACE-I) prevent the aortic elastin loss in experimental hypercholesterolaemia. Two doses of ACE-I (captopril, enalapril and quinapril) were used: a dose equivalent to that applied to human subjects and a dose 10 times higher. We found that the increase in serum and aortic elastolytic activity in cholesterol-fed rabbits was prevented by high-dose captopril. The elastin content in aorta homogenates from cholesterol-fed rabbits was significantly decreased. The higher dose of captopril, but no other ACE-I, prevented this decrease in aortic elastin content. In cholesterol-fed rabbits the elastin-bound calcium content was significantly elevated. The higher doses of captopril and enalapril lowered the elastin-bound calcium content. In serum and aortic homogenates of cholesterol-fed rabbits, ACE activity was elevated by 15% and 77%, respectively. Both doses of captopril, enalapril and quinapril prevented this cholesterol-induced increase in serum and aortic ACE activity. We conclude that: 1) administration of captopril at doses 10 times higher than those used in humans prevents hypercholesterolaemia increased aortic elastin loss. 2) higher doses of captopril and enalapril prevent the hypercholesterolaemia-induced increase in aortic elastin-bound calcium.
References
- Ross R., Glomset JA The pathogenesis of atherosclerosis. Part I. N Engl J Med 1976;1:277-82.
- Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;2:115-26.
- Rabinovitch M. Elastase and elastase inhibitors and pulmonary and coronary artery disease. Jacotot B (ed): Atherosclerosis XI Elsevier Science BV Amsterdam 1998:317-26.
- Cowan D., Langile BL Cellular and molecular biology of vascular remodeling. Curr Opin Lipidol 1996;7:94-100.[Web of Science][Medline]
[Order article via Infotrieve]
- Robert AM, Robert L. Biology and pathology of elastic tissues. Front Matrix Biol 1980; 8:140-3.
- Robert L., Robert AM Elastin, elastase and arteriosclerosis. Front Matrix Biol 1980;8:130-73.
- Chrysant SG Vascular remodeling: the role of angiotensin converting enzyme inhibitors. Am Heart J 1998;135: 21-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Strawn WB, Dean RH, Ferrario CM Novel mechanisms linking angiotensin II and early atherogenesis. JRAAS 2000;1:11-17.[Medline]
[Order article via Infotrieve]
- Holtz J. Renin-angiotensin system. In: Dominiak P, Boenner G (eds) ACE-hemmer in klinik und praxis. Springer Verlag, Berlin, Heidelberg 1995:3-36.
- Hornebeck W., Potazman JP, De Cremoux H. et al. Elastase type activity of human serum. Clin Physiol Biochem 1983;1:285-2.[Web of Science][Medline]
[Order article via Infotrieve]
- Scott-Burden T., Hanh WH, Resink TJ et al. Modulation of extracellular matrix by angiotensin II: Stimulated glycoconiugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol 1990;16:36-41.
- Tokimitsu I., Kato H.,Wachi H. et al. Elastin synthesis is inhibited by angiotensin II but not by platelet-derived growth factor in arterial smooth muscle cells. Biochim Biophys Acta 1994;1207:68-73.[CrossRef][Medline]
[Order article via Infotrieve]
- Chobanian AV, Haudenschild ChC, Nickerson C. et al. Antiathrogenic effect of captopril in the Watanebe Heritable Hyperlipidemic rabbit. Hypertension 1990;15:327-331.[Abstract/Free Full Text]
- Chobanian AV, Haudenschild ChC, Nickerson C. et al. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1992;20:473-77.[Abstract/Free Full Text]
- Becker RHA ACE-Hemmung und atherosklerose im tiermodell. Z Kardiol 1994;83(4):15-20.
- Schuh JR, Blehm DJ, Frierdich GE et al. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993;91:1453-8.[Web of Science][Medline]
[Order article via Infotrieve]
- Robert L., Hornebeck W. Preparation of insoluble and soluble elastin. In: Hall DA (ed.) The methodology of connective tissue research. Joynson-Bruvvers Ltd: Oxford 1983:81-104.
- Ito H., Kwan CY, Daniel EE Succinyl trialanine p-nitroanilide hydrolytic activity in blood vessels of the rat. Am J Physiol 1986;251: H247-H252.[Web of Science][Medline]
[Order article via Infotrieve]
- Cohen JR, Mandell C., Wise L. Characterisation of human elastase found in patients with abdominal aneurysms. Surgery 1987;165:301-4.[Web of Science]
- Aberg G., Ferrer P. Effects of captopril on atherosclerosis in cynomologus monkeys. J Cardiovasc Pharmacol 1990;15(Suppl. 5):S65-S72.[CrossRef]
- AvolioA.,Jones D.,Tafazzoli-Shadopour M. Quantification of alterations in structure and function of elastin in arterial media. Hypertension 1998;32:170-5.[Abstract/Free Full Text]
- Safar ME, Girerd X., Laurent S. Structural changes of large condiut arteries in hypertension. J Hypertens 1996;14:545-55.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bizbiz L., Alperovitch A., Robert L. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study. Atherosclerosis 1997;131:73-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hornebeck W.,Adnett JJ, Robert L.Age dependent variation of elastin and elastase in aorta and human breast cancers. Exp Gerontol 1978;13:293-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gminski J., Drózdz M., Ulfig-Maslanka R. et al. Evaluation of elastin metabolism in children from families with high risk of atherosclerosis. Atherosclerosis 1991;91:185-9.[CrossRef][Medline]
[Order article via Infotrieve]
- Gaballa MA, Jacob CT, RayaTE et al. Large artery remodeling during aging. Hypertension 1998;32:437-43.[Abstract/Free Full Text]
- Gminski J., Drózdz M. Succinyl trialanine p-nitroanilide hydrolytic activities in plasma and the aorta of rabbits experimentally immunized with soluble elastin. Exp Pathol 1991; 43:37-40.[Web of Science][Medline]
[Order article via Infotrieve]
- Altuntas Y., Guven M., Ince E., Acbay O., Caner M. and Kanigur-Sultuybek G.: The in vitro effects of captopril on the levels of lipid peroxidation and glutathione of erythrocytes in type II diabetes. J Basic Clin Physiol Pharmacol 1995;6:281-8.[Medline]
[Order article via Infotrieve]
- Jackson RL, Ku G. and Thomas CE: Antioxidants:A biological defense mechanism for the prevention of atherosclerosis. Med Res Rev 1993;13:161-82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wojakowski W., Gminski J., Siemianowicz K., Goss M., Machalski M.The influence of angiotensin - converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia. Int J Molecular Medicine 2000;6:591-4.
- Robert L., Robert AM Elastin, elastase and atherosclerosis revisited.Atherosclerosis 1998;140:281-95.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Watson KE, Demer LL The atherosclerosis-calcification link? Curr Opin Lipidol 1996;7:101-4.[Web of Science][Medline]
[Order article via Infotrieve]
- Sokolova RI Mediacalcinosis of the aorta - pathomorphology and pathogenesis of arterial calcification and its relationship to atherosclerosis.Arkh Patol 1996;58:31-5.[Medline]
[Order article via Infotrieve]
- Podet EJ, Shaffer DR, Gianturco SH Interaction of low density lipoproteins with human aortic elastin. Arterioscler Thromb Vasc Biol 1991;11:116-22.[Abstract/Free Full Text]
- Niederhoffer N., Lartaud-Idjouadiene I., Giummelly P. et al. Calcification of medial elastic fibers and aortic elasticity. Hypertension 1997;29:999-1006.[Abstract/Free Full Text]
- Mohler ER, Adam LP, McClelland P. et al. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997;17:547-52.[Abstract/Free Full Text]
- Hornebeck W. On the degradation of elastin fibers by elastases. Biochime des tissus conjonctifs normaux et pathologiques. 6th Coll. Fed. Eur. Conn. Tiss Clubs 1980;11: 115-24.
- McGuffee LJ, Little SATunica media remodelling in mesenteric arteries of hypertensive rats. Anat Rec 1996;246:279-92.[CrossRef][Medline]
[Order article via Infotrieve]
- Ricci MA, Slaiby JM, Hendley ED et al. Hemodynamic and biochemical characteristics of the aorta in WKY, SHR, WKHT and WKHA rat strains. Ann N Y Acad Sci 1996;800:121-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Marque V., Kieffer P., Atkinson J. et al. Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats. Hypertens 1999;34:415-22.[Abstract/Free Full Text]
- Augier T., Charpiot P., Chareyre C. et al. Medial elastic structure alterations in atherosclerotic arteries in minipigs: plaque proximity and arterial site specificity. Matrix Biol 1997;15:455-67.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Robert L., Jacob MP, Frances C. et al. Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A Review. Mechanisms of ageing and development 1984;28:155-66.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Oho S., Daley SJ, Koo EWY et al. Increased elastin-degrading activity and neointimal formation in porcine aortic organ culture.AtherosclerThromb Vasc Biol 1995;15:2200-6.
- Diet F.,Pratt RE, Berry GJ et al. Increased accumulation of tissue ACE in human atherosclerotic plaque. Circulation 1999;94:2756-67.
- Mitani H., Bandoh T., Kimura M. et al. Increased activity of vascular ACE related to atherosclerotic lesions in hyperlipidemic rabbits. Am J Physiol 1996;271:H1065-71.[Medline]
[Order article via Infotrieve]
- Hornebeck W., Robert L. Interaction between elastic fibers and cells. Front Matrix Biol 1986;11:58-77.
- Henney AM, Wakeley PR, Davies MJ et al. Localisation of stromelysin gene expression in atherosclerotic plaques by in situ hybrydisation. Proc Natl Acad Sci USA 1991;88:8154-58.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1,
37-42 (2001)
DOI: 10.3317/jraas.2001.006

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Suganuma, V. R. Babaev, M. Motojima, Y. Zuo, N. Ayabe, A. B. Fogo, I. Ichikawa, M. F. Linton, S. Fazio, and V. Kon
Angiotensin Inhibition Decreases Progression of Advanced Atherosclerosis and Stabilizes Established Atherosclerotic Plaques
J. Am. Soc. Nephrol.,
August 1, 2007;
18(8):
2311 - 2319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Suganuma, Y. Zuo, N. Ayabe, J. Ma, V. R. Babaev, M. F. Linton, S. Fazio, I. Ichikawa, A. B. Fogo, and V. Kon
Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction
J. Am. Soc. Nephrol.,
February 1, 2006;
17(2):
433 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Ahimastos, A. K. Natoli, A. Lawler, P. A. Blombery, and B. A. Kingwell
Ramipril Reduces Large-Artery Stiffness in Peripheral Arterial Disease and Promotes Elastogenic Remodeling in Cell Culture
Hypertension,
June 1, 2005;
45(6):
1194 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nobuhiko, E. Suganuma, V. R. Babaev, A. Fogo, L. L. Swift, M. F. Linton, S. Fazio, I. Ichikawa, and V. Kon
Angiotensin II Amplifies Macrophage-Driven Atherosclerosis
Arterioscler Thromb Vasc Biol,
November 1, 2004;
24(11):
2143 - 2148.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|